Sell Divi's Laboratories, target Rs 475.0 : Manas Jaiswal
Sell Divi's Laboratories Ltd. at a price target of Rs 475.0 and a stop loss at Rs 606.0 from entry point
Manas Jaiswal of manasjaiswal.com has a sell call on Divi's Laboratories Ltd. with a target price of Rs 475. The current market price of Divi's Laboratories Ltd. is Rs 595.8 Time period given by analyst is Intra Day when Divi's Laboratories Ltd. price can reach defined target. Manas Jaiswal maintains stop loss at Rs 606.0 .
Divi's Laboratories Ltd., incorporated in the year 1990, is a largecap company (with a market cap of ₹ 15816.62 crore) operating in Pharmaceuticals and health care sector.
Divi's Laboratories Ltd. key Products/Revenue Segments include Active Pharma Ingredients which contributed ₹ 3735.24 Cr to Sales Value (99.61 % of Total Sales), Contract Fees which contributed ₹ 7.24 Cr to Sales Value (0.19 % of Total Sales), Scrap which contributed ₹ 5.35 Cr to Sales Value (0.14 % of Total Sales) and Export Incentives which contributed ₹ 2.02 Cr to Sales Value (0.05 % of Total Sales)for the year ending 31-Mar-2016.
For the quarter ended 31-12-2016, the company has reported a Standalone sales of ₹ 973.44 Cr., down 2.95% from last quarter Sales of ₹ 1003.07 Cr. and up 13.37% from last year same quarter Sales of ₹ 858.65 Cr. Company has reported net profit after tax of ₹ 268.32 Cr. in latest quarter. The company’s CEO is Dr.Murali K Divi. It's Board of Directors include Mr.P V Lakshmi Rajani, Dr.G Suresh Kumar, Dr.Murali K Divi, Mr.A M L Punna Rao, Mr.G Hemanth Kumar, Mr.G Veeraiah Chowdary, Mr.K Subba Rao, Mr.K V K Seshavataram, Mr.Kiran S Divi, Mr.L Kishore Babu, Mr.L Ramesh Babu, Mr.L V Ramana, Mr.M Ramesh Babu, Mr.Madhusudana Rao Divi, Mr.N V Ramana, Mr.P Ramaiah Chowdary, Mr.P Srinivasa Rao, Mr.P V Lakshmi Rajani, Mr.R Ranga Rao, Mr.S Devendra Rao, Mr.S Ramakrishna, Mr.Satya Prakash Divi, Mr.V Naga Sekhar, Mr.Y S Koteswara Rao, Mr.Y T S Prasad, Mrs.S Sridevi. Company has its registered office at 7-1-77/E/1/303,, Divi Towers,, Dharam Karan Road,, Hyderabad, 500016, Andhra Pradesh. Company has P V R K Nageshwara Rao & Co. as its auditors. As on 31-03-2017, the company has a total of 265,468,580 shares outstanding.
Divi's Laboratories Ltd., incorporated in the year 1990, is a largecap company (with a market cap of ₹ 15816.62 crore) operating in Pharmaceuticals and health care sector.
Divi's Laboratories Ltd. key Products/Revenue Segments include Active Pharma Ingredients which contributed ₹ 3735.24 Cr to Sales Value (99.61 % of Total Sales), Contract Fees which contributed ₹ 7.24 Cr to Sales Value (0.19 % of Total Sales), Scrap which contributed ₹ 5.35 Cr to Sales Value (0.14 % of Total Sales) and Export Incentives which contributed ₹ 2.02 Cr to Sales Value (0.05 % of Total Sales)for the year ending 31-Mar-2016.
For the quarter ended 31-12-2016, the company has reported a Standalone sales of ₹ 973.44 Cr., down 2.95% from last quarter Sales of ₹ 1003.07 Cr. and up 13.37% from last year same quarter Sales of ₹ 858.65 Cr. Company has reported net profit after tax of ₹ 268.32 Cr. in latest quarter. The company’s CEO is Dr.Murali K Divi. It's Board of Directors include Mr.P V Lakshmi Rajani, Dr.G Suresh Kumar, Dr.Murali K Divi, Mr.A M L Punna Rao, Mr.G Hemanth Kumar, Mr.G Veeraiah Chowdary, Mr.K Subba Rao, Mr.K V K Seshavataram, Mr.Kiran S Divi, Mr.L Kishore Babu, Mr.L Ramesh Babu, Mr.L V Ramana, Mr.M Ramesh Babu, Mr.Madhusudana Rao Divi, Mr.N V Ramana, Mr.P Ramaiah Chowdary, Mr.P Srinivasa Rao, Mr.P V Lakshmi Rajani, Mr.R Ranga Rao, Mr.S Devendra Rao, Mr.S Ramakrishna, Mr.Satya Prakash Divi, Mr.V Naga Sekhar, Mr.Y S Koteswara Rao, Mr.Y T S Prasad, Mrs.S Sridevi. Company has its registered office at 7-1-77/E/1/303,, Divi Towers,, Dharam Karan Road,, Hyderabad, 500016, Andhra Pradesh. Company has P V R K Nageshwara Rao & Co. as its auditors. As on 31-03-2017, the company has a total of 265,468,580 shares outstanding.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
3 top stock recommendations from Manas JaiswalADVERTISEMENT
